RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
RT @bottomlineibd: How doctors convey this info to #IBD patients will be vital. Keeping us reassured and informed has the potential to make…
Inspiring effort from team Exeter-spearheaded participation from 7000 patients at 92 UK centres all recruited in 3 months @clarityibd
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/s8IVo7ugSh
RT @clarityibd: **HOT NEWS** First CLARITY IBD Data is out. 🦠IBD IFX Vs IBD VEDO shows NO difference in COVID19 infections. 🧿Potential I…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @ibdnurse: @researchstockp1 we are one of the sites for this study published in @Gut_BMJ ...... very proud @GastroNW https://t.co/Ss65zc…
RT @DelthiaRicks: Biologic drug prescribed for inflammatory bowel disease blunts the immune response to Covid infection. Infliximab is a p…
RT @DelthiaRicks: Biologic drug prescribed for inflammatory bowel disease blunts the immune response to Covid infection. Infliximab is a p…
RT @DelthiaRicks: Biologic drug prescribed for inflammatory bowel disease blunts the immune response to Covid infection. Infliximab is a p…
RT @DelthiaRicks: Biologic drug prescribed for inflammatory bowel disease blunts the immune response to Covid infection. Infliximab is a p…
RT @Gut_BMJ: Read the paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @ClaireBewshea "Anti-SARS-CoV-2 antibody resp…
RT @Gut_BMJ: Read the paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @ClaireBewshea "Anti-SARS-CoV-2 antibody resp…
RT @Gut_BMJ: #GUTInTheNews #GUTPressRelease - read the important paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @C…
Good points from @bottomlineibd
RT @Gut_BMJ: #GUTInTheNews #GUTPressRelease - read the important paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @C…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @Gut_BMJ: #GUTInTheNews #GUTPressRelease - read the important paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @C…
RT @clarityibd: **HOT NEWS** First CLARITY IBD Data is out. 🦠IBD IFX Vs IBD VEDO shows NO difference in COVID19 infections. 🧿Potential I…
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/s8IVo7ugSh
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @UKGastroDr: Pleased that our team at @ResearchKgh contributed to this @FarhadPeerally2 https://t.co/n9uDRc1NX8
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @DelthiaRicks: Biologic drug prescribed for inflammatory bowel disease blunts the immune response to Covid infection. Infliximab is a p…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @Gut_BMJ: #GUTInTheNews #GUTPressRelease - read the important paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @C…
RT @FachalLaura: A drug used to treat immune mediated diseases like #IBD or #RA, Infliximab, is associated with attenuated serological resp…
Anti-SARS-CoV-2 antibody response attenuated by IBD treatments. Implications for vaccine? https://t.co/XpLVw9PkIr
RT @FachalLaura: A drug used to treat immune mediated diseases like #IBD or #RA, Infliximab, is associated with attenuated serological resp…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @DelthiaRicks: Biologic drug prescribed for inflammatory bowel disease blunts the immune response to Covid infection. Infliximab is a p…
RT @DelthiaRicks: Biologic drug prescribed for inflammatory bowel disease blunts the immune response to Covid infection. Infliximab is a p…
RT @DelthiaRicks: Biologic drug prescribed for inflammatory bowel disease blunts the immune response to Covid infection. Infliximab is a p…
Biologic drug prescribed for inflammatory bowel disease blunts the immune response to Covid infection. Infliximab is a powerful monoclonal antibody. The impairment it causes may boost susceptibility to recurrent Covid & drive the evolution of new vari
RT @clarityibd: **HOT NEWS** First CLARITY IBD Data is out. 🦠IBD IFX Vs IBD VEDO shows NO difference in COVID19 infections. 🧿Potential I…
@clarityibd, run out of Exeter. It’s a great place to work, a beautiful place to live ❤️ - with the added bonus of conducting some v.exciting research with some amazing people, counting my lucky 🌟🌟 #Covid19UK #exeter #lovedevon #loveexeter #collaboration
RT @ImperialMDR: An important new paper co-authored by MDR's @NickPowellLab "Anti-SARS-CoV-2 antibody responses are attenuated in patients…
RT @Gut_BMJ: #GUTInTheNews #GUTPressRelease - read the important paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @C…
An important new paper co-authored by MDR's @NickPowellLab "Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab" 👇
RT @AshkanRA: 🚨 New data from @clarityibd in @Gut_BMJ : 📌Anti-SARS-CoV-2 antibody responses attenuated in IBD pts treated with infliximab…
RT @Gut_BMJ: #GUTInTheNews #GUTPressRelease - read the important paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @C…
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
RT @Gut_BMJ: #GUTInTheNews #GUTPressRelease - read the important paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @C…
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
RT @AshkanRA: 🚨 New data from @clarityibd in @Gut_BMJ : 📌Anti-SARS-CoV-2 antibody responses attenuated in IBD pts treated with infliximab…
RT @DrPhil_Gu: #COVID19 ab response in IFX vs VDZ treated #IBD pts 📍Similar rates of 🤢 📍⬇️seroprevalence in IFX 📍Seroconversion: IFX 48…
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/s8IVo7ugSh
RT @bottomlineibd: How doctors convey this info to #IBD patients will be vital. Keeping us reassured and informed has the potential to make…
RT @Gut_BMJ: Read the paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @ClaireBewshea "Anti-SARS-CoV-2 antibody resp…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @RichardPollok: Amazing effort from research team and IBD nurses @StGeorgesTrust that contributed to this study @clarityibd @Gut_BMJ
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
RT @j0nnymac1: -1st publication from @clarityibd study!! -Great example of collaborative UK research -Answering important #COVID19 question…
RT @j0nnymac1: -1st publication from @clarityibd study!! -Great example of collaborative UK research -Answering important #COVID19 question…
RT @AshkanRA: 🚨 New data from @clarityibd in @Gut_BMJ : 📌Anti-SARS-CoV-2 antibody responses attenuated in IBD pts treated with infliximab…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @ExeterMed: 2/3 Read the full paper here: https://t.co/cjImkG7CFP
RT @j0nnymac1: -1st publication from @clarityibd study!! -Great example of collaborative UK research -Answering important #COVID19 question…
RT @FachalLaura: A drug used to treat immune mediated diseases like #IBD or #RA, Infliximab, is associated with attenuated serological resp…
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
RT @clarityibd: **HOT NEWS** First CLARITY IBD Data is out. 🦠IBD IFX Vs IBD VEDO shows NO difference in COVID19 infections. 🧿Potential I…
RT @clarityibd: **HOT NEWS** First CLARITY IBD Data is out. 🦠IBD IFX Vs IBD VEDO shows NO difference in COVID19 infections. 🧿Potential I…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @RichardPollok: Amazing effort from research team and IBD nurses @StGeorgesTrust that contributed to this study @clarityibd @Gut_BMJ htt…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @Gut_BMJ: Read the paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @ClaireBewshea "Anti-SARS-CoV-2 antibody resp…
2/3 Read the full paper here: https://t.co/cjImkG7CFP
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
Great work at pace by the gastro research community across the uk
RT @Gut_BMJ: #GUTInTheNews #GUTPressRelease - read the important paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @C…
Well done @clarityibd @ExeterMed @RDEhospitals
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
RT @bottomlineibd: Vitally important research on how #IBD therapies influence the response to COVID infection in patients. Thanks @clarityi…
RT @bmj_company: Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response…
Infliximab, a powerful biologic that is used to treat inflammatory bowel disease (IBD), blunts the body’s immune response to #COVID19 infection, indicates new research in @Gut_BMJ https://t.co/FS5oS7nIks
RT @Gut_BMJ: #GUTInTheNews #GUTPressRelease - read the important paper by @clarityibd team @tariqahmadIBD @DrNickKennedy @JamesGoodhand1 @C…
Vitally important research on how #IBD therapies influence the response to COVID infection in patients. Thanks @clarityibd. For me, the main takeaway is the importance of staying well and having slick access to info and care. #patientcomms https://t.co/Q
👇
RT @RichardPollok: Amazing effort from research team and IBD nurses @StGeorgesTrust that contributed to this study @clarityibd @Gut_BMJ
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
@UKCPAGastro @AnjaStClairJone @UchuMeade
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
A drug used to treat immune mediated diseases like #IBD or #RA, Infliximab, is associated with attenuated serological responses to SARS-CoV-2 in an IBD cohort Great work by @clarityibd team @DrNickKennedy @tariqahmadIBD @JamesGoodhand1 @ClaireBewshea @doc_
RT @j0nnymac1: -1st publication from @clarityibd study!! -Great example of collaborative UK research -Answering important #COVID19 question…
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
RT @j0nnymac1: -1st publication from @clarityibd study!! -Great example of collaborative UK research -Answering important #COVID19 question…
RT @AshkanRA: 🚨 New data from @clarityibd in @Gut_BMJ : 📌Anti-SARS-CoV-2 antibody responses attenuated in IBD pts treated with infliximab…
RT @charlie_lees: The first data from @clarityibd are out @Gut_BMJ 6935 IBD patients from 92 UK sites on infliximab or vedolizumab. Data…
RT @AshkanRA: 🚨 New data from @clarityibd in @Gut_BMJ : 📌Anti-SARS-CoV-2 antibody responses attenuated in IBD pts treated with infliximab…
RT @ClaireBewshea: Amazing effort by the whole team. Huge THANK YOU 🙏🙏🙏to #marianparkinson and #helengardnerthorpe, @rachelnice3 @ExeterIBD…
RT @IBD_FloMD: Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab https://t.co/s8IVo7ugSh